Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
Sign Up to like & getrecommendations! Published in 2018 at "Intensive Care Medicine"
DOI: 10.1007/s00134-018-5068-1
Abstract: Initial correspondence from Drs. Yamaga, Ohshimo and Shime We would like to discuss factors that potentially affect the results of a biomarker-based antifungal therapeutic algorithm in a recent issue of Intensive Care Medicine [1]. First,… read more here.
Keywords: medicine; antifungal therapy; confounders interpreting; biomarker based ... See more keywords
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
Sign Up to like & getrecommendations! Published in 2020 at "Mycoses"
DOI: 10.1111/myc.13100
Abstract: Fungal infections are a major complication of neutropaenia following chemotherapy. Their early diagnosis is difficult, and empirical antifungal treatment is widely used, and uses of less toxic drugs that reduce breakthrough infection are required. read more here.
Keywords: liposomal amphotericin; empirical antifungal; itraconazole compared; amphotericin empirical ... See more keywords
Appropriate empirical antifungal therapy is associated with a reduced mortality rate in intensive care unit patients with invasive fungal infection: A real-world retrospective study based on the MIMIC-IV database
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.952611
Abstract: Objective The study aimed to determine the prevalence and pathogens of invasive fungal infection (IFI) among intensive care unit (ICU) patients. The next goal was to investigate the association between empirical antifungal treatment and mortality… read more here.
Keywords: intensive care; antifungal therapy; antifungal; icu patients ... See more keywords